-
Heparin TOP5 listed pharmaceutical companies Fawei, half a year a total of nearly 10 billion
Time of Update: 2022-10-13
According to Hepalink's semi-annual report, in the first half of 2022, the company's global sales of enoxaparin sodium preparations exceeded 114 million pieces, and the year-on-year sales volume in domestic sales terminals and overseas markets that have been opened up has achieved double-digit growth, of which the year-on-year sales growth in the US market has reached 184.
-
Clariant's SynDane® catalyst powers Wanhua's new world-class maleic anhydride production plant
Time of Update: 2022-08-17
Wanhua Chemical chooses Clariant SynDane catalyst for its upcoming world-class maleic anhydride production plant with an annual output of 200,000 tons, and selects Clariant's EnviCat® N2O-S catalyst for nitrous oxide emission reduction●● Wanhua adopts a new and more efficient production process technology.
-
The clinical trial application of recombinant human parathyroid hormone for injection, a wholly-owned subsidiary of Buchang Pharmaceuticals, has been accepted
Time of Update: 2022-01-12
On December 1, Buchang Pharmaceutical issued an announcement stating that its wholly-owned subsidiary Luzhou Buchang’s "recombinant human parathyroid hormone (1-84) for injection" clinical trial application was recently accepted by the National Medical Products Administration.
-
JCEM: Hypoadrenal medulla dysfunction predicts acute disease in infants with typical congenital adrenal hyperplasia
Time of Update: 2021-11-02
Adolescents with classic congenital adrenal hyperplasia (CAH) show abnormal adrenal medulla dysfunction, and decreased adrenaline levels in neonates and infants .
Figure 2 Plasma adrenaline levels in neonates and 1 year old patients with classic congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency.
-
2021 China's bulk chemical projects welcome the peak of production
Time of Update: 2021-10-25
First of all, starting from the seven major refining and chemical bases planned by China, China’s chemical industry has chosen to take the route of large-scale development, and the start of production of the first phase of Zhejiang Petrochemical in 2019 indicates that China’s seven major refining and chemical bases will usher in a boom , So 2021 is also one of the years when China’s chemical industry will be put into production.
-
Four major measures to ensure stable production and supply of important agricultural products
Time of Update: 2021-09-19
The second measure is to do a good job in the prevention and control of severe weather and major animal and plant epidemics, improve subsidies, insurance and other policies to avoid sudden factors that have a major impact on the production and supply of agricultural products .
-
What is going on when the nucleic acid test is positive but not contagious
Time of Update: 2021-06-21
" At a recent press conference of the Joint Prevention and Control Mechanism of the State Council, when answering a question from a reporter from Science and Technology Daily about the positive nucleic acid caused by the vaccine, China Disease Wang Huaqing, chief expert of the Control Center's immunization program, said that ordinary people do not have to worry if they are tested positive for nucleic acid caused by the vaccine .
-
"The 14th Five-Year Plan" my country's chemical industry is in urgent need of transformation and upgrading to achieve "butterfly change
Time of Update: 2021-06-17
In 6 Yue 8 on "Yangtze River economic belt and the joint development of Jiangsu Chemical industrial transformation and upgrading," Day seminar held in Nanjing, experts believe that "Fourteen Five-Year" period, China's chemical industry aimed at urgent market demand, optimize the industrial structure, Adjust the industrial layout, build optimized industrial parks, and promote green, low-carbon, and high-quality development .
-
Desert locusts are approaching our country! Experts caution: Be alert to potential threats
Time of Update: 2021-03-04
China's Tibet Autonomous Region border area with Pakistan, India and Nepal is a desert locust proliferation area, but due to environmental, climatic and food constraints, china's agricultural production is not a threat.
-
Academician Gao Fu: The country entered the final extinguishing stage of the new crown
Time of Update: 2021-02-23
2019, several cases of UNexplained pneumonia (PUE) were reported in Wuhan, Hubei Province, and the COVID-19 disease caused by a virus called SARS-CoV-2 was finally diagnosed in January 2020, Gaofu wrote.
-
Scientists have discovered fruit substitutes for toxic insect repellents
Time of Update: 2021-02-05
In recent years, scientists have become increasingly interested in detecting plant resistance to pests, for example, when a team of researchers recently studied how a plant's chemical distress signals were turned into a weapon against pests.
-
Expert: The new coronavirus will not self-replicate and multiply in the external environment
Time of Update: 2020-11-30
Relevant staff after isolation of medical observation and nucleic acid testing, there is no infection, then public places can be reopened, reopened, and other similar public places of daily prevention and control is no different.
-
Bill Gates: Multi-country outbreaks are responding faster than the United States
Time of Update: 2020-08-05
Bill Gates, co-chairman of the Gates Foundation, said in an interview with U.S. media that the U.S. is lagging behind many countries in the response to the new outbreak of pneumonia, which affects the world.
-
Policy . . . During the "two sessions", Beijing, Hebei, Henan dangerous goods transport restrictions
Time of Update: 2020-05-28
the two sessions of the National People's Congress is a major event in the political life of our people, which has always attracted attention at home and abroad In previous years, March 3 is an impo
-
Weigh! Junshi independent research and development, the first domestic PD-1 monoclonal antibody officially approved
Time of Update: 2018-12-17
On December 17, the State Drug Administration had the conditions to approve the first domestic PD-1 monoclonal antibody - treprizumab injection (trade name: tuoyi) This is an innovative biological pro
